Patent Assignment
Reel/Frame 047837/0451
Assignment of Assignor's Interest
Recorded: 2018-12-20
Pages: 3
Assignor
LIN, WU
Executed: 2016-07-28
Assignee
QUOTIENT CLINICAL LIMITED
TRENT HOUSE, MERE WAY, RUDDINGTON FIELDS BUSINESS PARK, RUDDINGTON, NOTTINGHAM, NG11 6JS, GREAT BRITAIN
Covered Property
(1)
Modified Release Formulations of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)Pyrazolo[3,4-D]Pyrimidin-1-Yl]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-Yl)Piperazin-1-Yl]Pent-2-Enenitrile
Application:
16/312,258 →
Publication:
US 2019/0231784
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 20, 2018
From: QUOTIENT CLINICAL LIMITED
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 047837/0417 →
Assignment of Assignor's Interest
Dec 20, 2018
From: MASJEDIZADEH, MOHAMMAD; FERDOUS, ABU
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 047837/0438 →
Assignee Change of Address
Mar 22, 2019
From: PRINCIPIA BIOPHARMA INC.
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 048675/0297 →
Assignee Change of Address
Sep 16, 2025
From: PRINCIPIA BIOPHARMA INC.
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 072881/0270 →